WuXi Biologics (2269)

Hong Kong
Currency in HKD
Disclaimer
42.65
+1.90
(+4.66%)
Closed
Day's Range
39.80
42.95
52 wk Range
35.00
77.40
Volume
16,598,304
Bid/Ask
42.60 / 42.65
Prev. Close
40.75
Open
40.35
Day's Range
39.8-42.95
52 wk Range
35-77.4
Volume
16,598,304
Average Volume (3m)
18,386,459
1-Year Change
-13.22%
Shares Outstanding
4,250,765,544
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
72.05
Upside +68.93%

People Also Watch

5.81
0857
+0.69%
25.200
1928
+2.02%
117,300
000660
+0.69%
41.90
0001
+1.82%
How do you feel today about 2269?
Vote to see community's results!
or

WuXi Biologics Company Profile

WuXi Biologics Cayman Inc is an investment holding company principally engaged in provision of discovery, development and manufacturing services of biologics. Through fully-integrated biologics Contract Research, Development and Manufacturing Organization (CRDMO), the Company provides one-stop end-to-end biologics services. Biologics development process stages include pre-IND (drug discovery and pre-clinical development), early-phase (phases I & II) clinical development, late-phase (phase III) clinical development and commercial manufacturing. The Company also offers end-to-end vaccine CRDMO services, including vaccine discovery and development, scale-up commercial manufacturing and global distribution. The Company has WuXiBody bispecific antibody platform, SDArBodY multispecific antibody platform, WuXia cell line development platform, WuXiUP continuous manufacturing platform and mRNA vaccine platform. The Company mainly operates its businesses in the domestic and overseas markets.

Employees
12373
Market
Hong Kong

Income Statement